At Mid-Ohio Behavioral Health, serving Columbus, OH, and Zanesville, OH, we are proudly committed to providing cutting-edge mental health treatments that will help individuals regain control of their lives. For those struggling with treatment-resistant depression, we can offer esketamine therapy. This is a groundbreaking option that has provided relief for many patients who have not responded to traditional antidepressants.
Mid-Ohio Behavioral Health: Innovative Treatment With Esketamine
Esketamine, an FDA-approved medication, is a fast-acting treatment designed to target the brain in a different way than conventional antidepressants. Unlike traditional medications that can take weeks to show results, esketamine works very rapidly, often providing relief within just hours or days. This makes it an excellent option for individuals facing severe depression, and those who need immediate and effective intervention.
One of the most trusted esketamine treatments that is available is Spravato, a prescription nasal spray that is administered in a clinical setting under medical supervision. Spravato has been shown to significantly improve symptoms of depression, particularly in patients who have not found success with other types of treatments. At Mid-Ohio Behavioral Health, our experienced providers carefully monitor each session to ensure patient safety and maximize treatment effectiveness.
Our approach to mental health care is comprehensive, combining esketamine therapy with other evidence-based treatments, including psychotherapy and medication management. We believe in a personalized approach, tailoring each treatment plan to meet the unique needs of our patients.
If you or a loved one is struggling with treatment-resistant depression, Mid-Ohio Behavioral Health is here to help. Our dedicated team is committed to offering compassionate, professional care while utilizing the latest advancements in mental health treatment.
Take the first step toward healing. Check out our locations then contact us today to learn more about how Spravato and esketamine therapy can provide new hope for lasting relief.